Regencell Bioscience Holdings Limited (RGC)

NASDAQ: RGC · Real-Time Price · USD

312.20

-157.82 (-33.58%)

At close: May 13, 2025, 4:00 PM

343.50

+31.30 (10.03%)

Pre-market: May 14, 2025, 6:12 AM EDT

RGC Cash Flow Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019
Period Ending	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	2019
Net Income	-4.3	-5.87	-7.45	-1.35	-0.81	Upgrade
Depreciation & Amortization	0.75	0.77	0.6	0.03	0.01	Upgrade
Loss (Gain) From Sale of Assets	-	0	-	-	-	Upgrade
Stock-Based Compensation	0.45	0.92	2.76	-	-	Upgrade
Other Operating Activities	-0.31	-0.28	-0.16	-	-	Upgrade
Change in Other Net Operating Assets	-0.59	-0.51	-1.02	0.55	0.08	Upgrade
Operating Cash Flow	-4	-4.96	-5.27	-0.77	-0.73	Upgrade
Capital Expenditures	-0.01	-0.03	-0.78	-	-0.12	Upgrade
Sale of Property, Plant & Equipment	-	0	-	-	-	Upgrade
Investment in Securities	5.25	0.09	-10	-	-	Upgrade
Investing Cash Flow	5.24	0.06	-10.78	-	-0.12	Upgrade
Short-Term Debt Issued	-	-	-	0.61	0.99	Upgrade
Total Debt Issued	-	-	-	0.61	0.99	Upgrade
Short-Term Debt Repaid	-	-	-0.43	-	-	Upgrade
Total Debt Repaid	-	-	-0.43	-	-	Upgrade
Net Debt Issued (Repaid)	-	-	-0.43	0.61	0.99	Upgrade
Issuance of Common Stock	-	-	22.67	-	-	Upgrade
Other Financing Activities	0.1	0.13	0.16	-0.17	-	Upgrade
Financing Cash Flow	0.1	0.13	22.41	0.44	0.99	Upgrade
Foreign Exchange Rate Adjustments	0.05	-0.08	-	-	-	Upgrade
Net Cash Flow	1.4	-4.85	6.36	-0.33	0.14	Upgrade
Free Cash Flow	-4.01	-4.99	-6.05	-0.77	-0.84	Upgrade
Free Cash Flow Per Share	-0.31	-0.38	-0.47	-0.08	-0.08	Upgrade
Levered Free Cash Flow	-1.88	-2.28	-2.69	-0.28	-0.52	Upgrade
Unlevered Free Cash Flow	-1.88	-2.28	-2.69	-0.28	-0.52	Upgrade
Change in Net Working Capital	0.13	0.03	0.51	-0.55	-0.1	Upgrade

Updated Oct 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q